USPTO serial 79341354
WHOPE HOME BLOOD MEDICAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 2, 2024
- Examiner
- RUSKIN, MATTHEW SEAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with WHOPE HOME BLOOD MEDICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
LEIGH ANN LINDQUIST
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC2000 PENNSYLVANIA AVENUE NW, SUITE 9000WASHINGTON, DC 20006UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific diagnostic devices for measuring relative DNA, RNA and protein and parts and fittings therefore; diagnostic chips for blood plasma testing, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use; diagnostic chips for testing blood, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use; diagnostic chips for blood analysis, namely, research laboratory analyzers for measuring, testing and analyzing blood; diagnostic chips for analyzing blood plasma, namely, research laboratory analyzers for measuring, testing and analyzing blood plasma; diagnostic chips for serum test, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use; diagnostic chips for testing sera, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; disposable lab-on-a-chip for diagnostic and medical use, namely, bio-chips for research or scientific purposes for manipulating, controlling and analyzing laboratory samples; lab-on-a-chip for diagnostic and medical use for nucleic acid testing; chips for measurement of antibody, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; biochips for diagnostic and medical use, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; chips for clinical laboratory test, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; medical diagnostic chips, namely, chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; protein chips for diagnostic and medical use, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; diagnostic and medical DNA chips; chips for addictive disease diagnosis, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; chips for tumour diagnosis, namely, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use | ACTIVE | — |
| 010 | Medical diagnostic immunity measuring devices, namely Immunoassay apparatus for measuring antibody levels for medical diagnosis; medical imaging diagnostic device; medical diagnostic imaging devices; diagnostic blood analysis device; in vitro diagnostic devices for medical purposes, namely, diagnostic apparatus for detection of molecular markers containing nucleic acids and diagnostic apparatus for detection of molecular markers containing proteins and for blood analysis; in vitro diagnostic devices for medical purposes, namely, ultrasound apparatuses; in vitro diagnostic devices for medical purposes for blood analysis; medical apparatus for the diagnosis of cardiovascular diseases; medical diagnostic testing instruments for detecting and measuring antibody levels for use in immunoassay procedure; medical diagnostic apparatus for performing blood analysis; diagnostic measuring apparatus for medical use, namely, wearable lower limb, upper limb and chest monitors for measuring and analyzing the quality of movement and motion patterns; diagnostic measuring apparatus for medical use, namely, apparatus for measuring glucose levels, temperature, posture, sleep, stress levels, blood pressure, international normalized ratio, and vital signs; apparatus for carrying-out diagnostic tests for medical purposes, namely, diagnostic apparatus for detection of molecular markers containing nucleic acids and diagnostic apparatus for detection of molecular markers containing proteins; remote measuring, diagnostic and monitoring apparatus for medical use, namely, medical apparatus for monitoring vital signs, blood properties, and respiratory events for the purpose of monitoring critically ill patients, monitoring septic patients, and detecting surgical complications; remote measuring, diagnostic and monitoring apparatus for medical use in the nature of medical apparatus for monitoring blood oxygen saturation, blood gas concentrations, blood properties and respiratory events; Remote measuring, diagnostic and monitoring apparatus for medical use for monitoring body temperate, blood pressure, heart rate, respiration, oxygen saturation, exhaled oxygen, electrocardiogram, stress levels; Medical diagnostic measuring apparatus for medical use for detecting cancer; medical apparatus and instruments in the fields of clinical diagnosis, namely, instruments for monitoring blood oxygen saturation, blood gas concentration, and vital signs; medical apparatus and instruments in the fields of clinical diagnosis, namely, flow cytometers for medical diagnostic uses, diagnostic penlights for medical purposes; Medical diagnostic, screening, and monitoring equipment, namely, medical diagnostic instruments for body fluid test and body fluid analysis; scanners for medical diagnosis, namely, ultrasound devices and X-ray CT scanners; sensor apparatus for monitoring blood properties and respiratory events for medical use in diagnosis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SMALL MACHINES
- Other trademarks owned by SMALL MACHINES
- Other trademarks owned by SMALL MACHINES
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named WHOPE HOME BLOOD MEDICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 22, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 3, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 3, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 2, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 21, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 1, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 1, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 17, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 17, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 16, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 27, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 27, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 8, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 8, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 8, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 8, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 8, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 6, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 6, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 6, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 6, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 6, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 6, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 6, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 10, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 10, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 16, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 15, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| May 31, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 27, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 26, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |